AIMC Topic: Drug Design

Clear Filters Showing 531 to 540 of 583 articles

Deep inverse reinforcement learning for structural evolution of small molecules.

Briefings in bioinformatics
The size and quality of chemical libraries to the drug discovery pipeline are crucial for developing new drugs or repurposing existing drugs. Existing techniques such as combinatorial organic synthesis and high-throughput screening usually make the p...

Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning.

Nucleic acids research
Vaccination is one of the most significant inventions in medicine. Reverse vaccinology (RV) is a state-of-the-art technique to predict vaccine candidates from pathogen's genome(s). To promote vaccine development, we updated Vaxign2, the first web-bas...

DeepAtomicCharge: a new graph convolutional network-based architecture for accurate prediction of atomic charges.

Briefings in bioinformatics
Atomic charges play a very important role in drug-target recognition. However, computation of atomic charges with high-level quantum mechanics (QM) calculations is very time-consuming. A number of machine learning (ML)-based atomic charge prediction ...

MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm.

Briefings in bioinformatics
Deep learning is an important branch of artificial intelligence that has been successfully applied into medicine and two-dimensional ligand design. The three-dimensional (3D) ligand generation in the 3D pocket of protein target is an interesting and ...

Application and assessment of deep learning for the generation of potential NMDA receptor antagonists.

Physical chemistry chemical physics : PCCP
Uncompetitive antagonists of the N-methyl d-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's, but some also cause dissociative effects that have led to the ...

Trends in Deep Learning for Property-driven Drug Design.

Current medicinal chemistry
It is more pressing than ever to reduce the time and costs for the development of lead compounds in the pharmaceutical industry. The co-occurrence of advances in high-throughput screening and the rise of deep learning (DL) have enabled the developmen...

Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research.

Current topics in medicinal chemistry
With the rapid development of computer science in scopes of theory, software, and hardware, artificial intelligence (mainly in form of machine learning and more complex deep learning) combined with advanced cheminformatics is playing an increasingly ...

Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.

Current drug discovery technologies
BACKGROUND: Machine learning is an active area of research in computer science by the availability of big data collection of all sorts prompting interest in the development of novel tools for data mining. Machine learning methods have wide applicatio...

Convolutional Neural Network-based Virtual Screening.

Current medicinal chemistry
Virtual screening is an important means for lead compound discovery. The scoring function is the key to selecting hit compounds. Many scoring functions are currently available; however, there are no all-purpose scoring functions because different sco...

An Analysis of QSAR Research Based on Machine Learning Concepts.

Current drug discovery technologies
Quantitative Structure-Activity Relationship (QSAR) is a popular approach developed to correlate chemical molecules with their biological activities based on their chemical structures. Machine learning techniques have proved to be promising solutions...